stella
beta
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome — Stella
Recruiting
Back to Acute Myeloid Leukemia trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(3 sites)
United States
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
Cleveland Clinic Foundation, Cleveland, Ohio
M D Anderson Cancer Center, Houston, Texas
View full record on ClinicalTrials.gov